Retour aux projets

16087.2 PFLS-LS

16087.2 PFLS-LS

Résumé

Development of molecules for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Textes supplémentaires

Abstract

We have discovered molecules that by modulating energy metabolism in astrocytes, a type of glial cell, have the potential to protect neurons and to decrease degeneration as it occurs in ALS. We plan to evaluate the effect of these molecules on an in-vivo ALS model. The more effective candidates will be patented and will be the first milestones for the creation of a company centered on the discovery of molecules targeting glial metabolism to treat brain diseases.

Participants

Pierre Magistretti

Kontaktperson

pierre.magistretti@epfl.ch

EPFL Pierre Magistretti Station 19 1015 Lausanne VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2014-08-31
Date de fin
2016-02-29
Coûts totaux approuvés
CHF 328860.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%